Waldenstrom macroglobulinemia

Waldenstrom macroglobulinemia survival rates are given by risk group. Other cancers might give survival rates by stage, but stages don't apply to Waldenstrom macroglobulinemia. Instead, healthcare professionals use risk groups to describe the seriousness of the cancer.

To decide on the risk group, the healthcare team uses the person's age and two blood tests, albumin and lactate dehydrogenase (LDH). People in the lower risk groups tend to live longer, while those in higher risk groups have a higher chance of dying of Waldenstrom macroglobulinemia.

Survival rates show the percentage of people with this cancer who are still alive a certain number of years after diagnosis. For example, a five-year survival rate means the percentage of people living five years after diagnosis.

The estimated five-year survival rates for each risk group:

• Low risk: about 93%.
• Low-intermediate risk: about 82%.
• Intermediate risk: about 69%.
• High risk: about 55%.

Keep in mind that survival statistics take five years to collect. The most recent survival rates include people who had treatment for Waldenstrom macroglobulinemia more than five years ago. These people may not have had access to the latest treatments.

Blood Cancers & Disorders Discussions

My Bone Marrow Transplant (BMT/SCT) story: Will you share yours?

814 Replies Sat, Jan 10, 2026

T cell large granulocytic leukemia

33 Replies Sat, Jan 10, 2026

High Ferritin Levels: How can I lower my levels?

32 Replies Wed, Jan 07, 2026